× Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our privacy policy



meta|IO

Living evidence synthesis
about Immuno-Oncology drugs

Member of the meta|Evidence galaxy

Pathology  

Latest studies

sotorasib NICE ITC Flatiron, 0

metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2)

sotorasib

sotorasib NICE ITC 1, 0

metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2)

sotorasib

ATEMPT, 2021

breast cancer - adjuvant

trastuzumab emtasine plus endocrine therapy

Bachelot, 2022

breast cancer - adjuvant

everolimus

Treatments

438
treatments 		  325
studies 		  1129
references
This project is supported by H2020 Qualitop, an EU-funded project, Hospices Civils de Lyon and CNRS UMR5558 LBBE.
     

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons